Glaukos (GKOS) Net Income towards Common Stockholders (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130.92% |
| Dec 31, 2025 | 494.18% |
| Sep 30, 2025 | 17.43% |
| Jun 30, 2025 | -8.48% |
| Mar 31, 2025 | -115.89% |
| Dec 31, 2024 | 632.71% |
| Sep 30, 2024 | 57.64% |
| Jun 30, 2024 | -23.77% |
| Mar 31, 2024 | -140.31% |
| Dec 31, 2023 | 432.76% |
| Sep 30, 2023 | 7.12% |
| Jun 30, 2023 | 5.34% |
| Mar 31, 2023 | -149.57% |
| Dec 31, 2022 | 353.75% |
| Sep 30, 2022 | 39.54% |
| Jun 30, 2022 | -942.79% |
| Mar 31, 2022 | 122.54% |
| Dec 31, 2021 | -484.83% |
| Sep 30, 2021 | 135.64% |
| Jun 30, 2021 | -6.15% |
| Mar 31, 2021 | -54.67% |
| Dec 31, 2020 | 32.39% |
| Sep 30, 2020 | 60.53% |
| Jun 30, 2020 | 26.20% |
| Mar 31, 2020 | -249.01% |
| Dec 31, 2019 | 368.61% |
| Sep 30, 2019 | -114.08% |
| Jun 30, 2019 | -370.12% |
| Mar 31, 2019 | -175.44% |
| Dec 31, 2018 | 126.87% |
| Sep 30, 2018 | -22.66% |
| Jun 30, 2018 | -99.11% |
| Mar 31, 2018 | -369.48% |
| Dec 31, 2017 | -24.08% |
| Sep 30, 2017 | 140.14% |
| Jun 30, 2017 | -475.97% |
| Mar 31, 2017 | -88.72% |
| Dec 31, 2016 | 571.53% |
| Sep 30, 2016 | -50.30% |
| Jun 30, 2016 | 159.98% |
| Mar 31, 2016 | -97.40% |
| Dec 31, 2015 | 1,751.96% |
| Sep 30, 2015 | 93.58% |
| Jun 30, 2015 | -2,123.80% |
| Mar 31, 2015 | 66.30% |
| Dec 31, 2014 | -191.34% |
| Sep 30, 2014 | 40.30% |
| Jun 30, 2014 | 38.08% |